BioFinance & BioInnovate Europe 2010

25 Mar 2010
0900 - 1700
Venue:
The Royal Institution of Great Britain, 21 Albemarle Street
London
W1S 4BSFind on Google maps


More information: https://www.bioindustry.org/cgi-bin/events.pl?CD=4110

The day will highlight the new mechanisms and ways of working that successful companies are embracing now. Contentious issues, such as how to foster innovation, the future of the IPO, and what can be learned from those companies which are making progress and raising money, will be debated. There will also be sessions on corporate venture funds, what to expect from Government-industry interaction in 2010, open innovation, and a workshop on the UK patent box.

The global biotech sector has survived the economic crisis, and this is the place in which to highlight its lessons, as well as ideas for the future. With speakers from big pharma, leading biotechnology companies, finance providers and the capital markets, this promises to be a productive and thought-provoking day.

Programme topics include:
The European Biotechnology Success Story Toolkit – Hear directly from the funders and the funded
The Translation of Fundamental Science into a Commercial Drug Discovery Company
One Year On – an update on the Office for Life Sciences
Money, Money, Money In the City – A panel discussion of the benefits of a Stock Market listing
Sizing up the Capital Markets and Utilising Alternative Financing Strategies to Grow your Life Science Business – New rules, strategies and tactics to win in this tough market
An investor‘s wishlist – What are Fund Managers and VCs Looking for in 2010 and Beyond
How Pfizer is Staying Innovative and Competitive in the New Decade
Nothing Ventured, Nothing Gained –The Increasing Importance of Corporate Venture Funds in the Life Sciences Sector

 
Who should attend:
CEO's, VP's, CFO's, CSO's
Business Development Executives
Licensing Executives
Technology Transfer Managers
Research and Development Scientists / Professionals

Attendees will gain:
Access to the finance sector
Access to alternative funding options
Access to key individuals within the biotech sector
Access to big pharma
Access to early stage, innovative companies
Access to partnering and network opportunities

To register, please go to: https://www.bioindustry.org/cgi-bin/events.pl?CD=4110